Upgrade to SI Premium - Free Trial

Synergy Pharmaceuticals (SGYP) Trulance Weekly Rx Trends Continue to Track Ahead of Projections - BTIG

May 31, 2017 6:58 AM
BTIG analyst Timothy Chiang reiterated a Buy rating and $11 price target on Synergy Pharmaceuticals (NASDAQ: SGYP) saying Trulance weekly ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments